RETRACTED ARTICLE: TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p

Abstract

Background The role of TMED3 involved in cancers has been seldom described, let alone in breast cancer. To explore the clinicopathological significance of TMED3 expression and the biological roles involved in breast cancer cells, we undertook the study. Methods Immunohistochemistry was performed to observe the pattern of TMED3 expression in breast cancer tissues, totaling 224 cases; followed by detailed statistical analysis between TMED3 expression versus clinicopathological information available. To explore the role of TMED3 involved in the malignant behaviors of breast cancer cells, wound-healing and Transwell assays were conducted to evaluate the variation of migration and invasion of MCF-7 and MDA-MB-231 cells whose TMED3 has been stably silenced using lenti-viral based short hairpin RNA (shRNA) vectors. MTT, clonogenic assay and xenograft nude mice model were undertaken to observe the variation of proliferation both in vitro and in vivo. Results It was shown that elevated TMED3 markedly correlated with ER, PR, Her-2 status, and lymph nodes metastases in addition to significant association with poor overall prognosis. In vitro, TMED3 was shown to promote proliferation, migration and invasion of breast cancer cells. Moreover, miR-188-3p was identified as a novel negative regulator of TMED3 in breast cancer, which can slow down the proliferation, migration and invasion of MCF-7 cells. Results from in vivo xenograft nude mice models showed that lenti-viral based miR-188-3p re-expression can markedly impair the tumor growth. Conclusions Our data define and bolster the oncogenic role of TMED3 in breast cancer. Electronic supplementary material The online version of this article (10.1186/s12935-019-0791-4) contains supplementary material, which is available to authorized users.

hsa_circ_0026827 Promotes Osteoblast Differentiation of Human Dental Pulp Stem Cells Through the Beclin1 and RUNX1 Signaling Pathways by Sponging miR-188-3p

“…BMSC-specific miR-188 inhibition by intra-bone marrow aptamer-antagomiR-188 injection increased bone formation ( Li et al, 2015 ). This study also verified that evoked miR-188-3p expression impaired cell proliferation, especially tumor cells ( Pei et al, 2019 ; Shi et al, 2019 ).…”

<p>CircRNA ZNF609 Knockdown Suppresses Cell Growth via Modulating miR-188/ELF2 Axis in Nasopharyngeal Carcinoma</p>

“…As a miRNA, miR-188 was reported to exert function in many types of cancer, such as colorectal cancer, 43 oral squamous cell carcinoma, 44 gastric cancer, 45 and breast cancer. 46 Besides, miR-188 acted as a regulator to repress proliferation, cycle transition, and colony formation of NPC cells. 25 Agreement with this result, our data revealed that miR-188 repressed cell growth in NPC.…”

Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity

“…Zhang et al [50] found that miR-188-3p might be a new potential therapy for atherosclerosis by inhibiting macrophage proinflammatory response and oxidation. Pei et al [51] found that miR-188-3p inhibited the cell proliferation and motility in breast cancer The seed region of miRNAs is underlined by targeting Transmembrane emp24 domain-containing protein 3 (TMED3). Pichler et al [52] identified miR-188-3p as a novel prognostic marker and molecular factor involved in colorectal carcinogenesis.…”